Non-Canonical Aspects of Antibiotics and Antibiotic Resistance

被引:5
作者
Amabile-Cuevas, Carlos F. [1 ]
Lund-Zaina, Sofia [2 ]
机构
[1] Fdn Lusara, Mexico City 08810, Mexico
[2] Univ Southern Denmark, Dept Publ Hlth, Campusvej 55, DK-5230 Odense, Denmark
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 06期
关键词
antibiotic resistance; horizontal gene transfer; antibiotic usage; socioeconomic factors; disinfectants; mechanism of action; mechanism of resistance; HORIZONTAL GENE-TRANSFER; GLOBAL ANTIMICROBIAL-RESISTANCE; VANCOMYCIN MIC CREEP; ESCHERICHIA-COLI; OXIDATIVE-STRESS; CONJUGATIVE TRANSFER; SUPEROXIDE STRESS; VIRULENCE GENES; NITRIC-OXIDE; PLASMID;
D O I
10.3390/antibiotics13060565
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The understanding of antibiotic resistance, one of the major health threats of our time, is mostly based on dated and incomplete notions, especially in clinical contexts. The "canonical" mechanisms of action and pharmacodynamics of antibiotics, as well as the methods used to assess their activity upon bacteria, have not changed in decades; the same applies to the definition, acquisition, selective pressures, and drivers of resistance. As a consequence, the strategies to improve antibiotic usage and overcome resistance have ultimately failed. This review gathers most of the "non-canonical" notions on antibiotics and resistance: from the alternative mechanisms of action of antibiotics and the limitations of susceptibility testing to the wide variety of selective pressures, lateral gene transfer mechanisms, ubiquity, and societal factors maintaining resistance. Only by having a "big picture" view of the problem can adequate strategies to harness resistance be devised. These strategies must be global, addressing the many aspects that drive the increasing prevalence of resistant bacteria aside from the clinical use of antibiotics.
引用
收藏
页数:45
相关论文
共 430 条
[61]   The Social Determinants of Health: It's Time to Consider the Causes of the Causes [J].
Braveman, Paula ;
Gottlieb, Laura .
PUBLIC HEALTH REPORTS, 2014, 129 :19-31
[62]   The oral microbiota of wild bears in Sweden reflects the history of antibiotic use by humans [J].
Brealey, Jaelle C. ;
Leitao, Henrique G. ;
Hofstede, Thijs ;
Kalthoff, Daniela C. ;
Guschanski, Katerina .
CURRENT BIOLOGY, 2021, 31 (20) :4650-+
[63]  
Brown H.J., 1996, Antibiotic Resistance: From Molecular Basics to Therapeutic Options, P19
[64]   Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study [J].
Browne, Annie J. ;
Chipeta, Michael G. ;
Haines-Woodhouse, Georgina ;
Kumaran, Emmanuelle P. A. ;
Hamadani, Bahar H. Kashef ;
Zaraa, Sabra ;
Henry, Nathaniel J. ;
Deshpande, Aniruddha ;
Reiner, Robert C., Jr. ;
Day, Nicholas P. J. ;
Lopez, Alan D. ;
Dunachie, Susanna ;
Moore, Catrin E. ;
Stergachis, Andy ;
Hay, Simon, I ;
Dolecek, Christiane .
LANCET PLANETARY HEALTH, 2021, 5 (12) :E893-E904
[65]   A Fundamental Change in Antibiotic Susceptibility Testing Would Better Prevent Therapeutic Failure: From Individual to Population-Based Analysis [J].
Brukner, Ivan ;
Oughton, Matthew .
FRONTIERS IN MICROBIOLOGY, 2020, 11
[66]   Zinc and Copper Reduce Conjugative Transfer of Resistance Plasmids from Extended-Spectrum Beta-Lactamase-Producing Escherichia coli [J].
Buberg, May Linn ;
Witso, Ingun Lund ;
L'Abee-Lund, Trine Marie ;
Wasteson, Yngvild .
MICROBIAL DRUG RESISTANCE, 2020, 26 (07) :842-849
[67]   Impact of vaccines on antimicrobial resistance [J].
Buchy, Philippe ;
Ascioglu, Sibel ;
Buisson, Yves ;
Datta, Sanjoy ;
Nissen, Michael ;
Tambyah, Paul Anantharajah ;
Vong, Sirenda .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 90 :188-196
[68]   HIV Drugs Inhibit Transfer of Plasmids Carrying Extended-Spectrum β-Lactamase and Carbapenemase Genes [J].
Buckner, Michelle M. C. ;
Ciusa, M. Laura ;
Meek, Richard W. ;
Moorey, Alice R. ;
McCallum, Gregory E. ;
Prentice, Emma L. ;
Reid, Jeremy P. ;
Alderwick, Luke J. ;
Di Maio, Alessandro ;
Piddock, Laura J., V .
MBIO, 2020, 11 (01)
[69]   Climate change and antibiotic resistance: a deadly combination [J].
Burnham, Jason P. .
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
[70]  
Butler MS, 2022, ANTIMICROB AGENTS CH, V66, DOI [10.1128/aac.01991-21, 10.1128/AAC.01991-21]